Stocks and Investing Stocks and Investing
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
Kostas Biliouris Maintained (BMRN) at Hold with Decreased Target to $102 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (ACRS) at Strong Buy with Decreased Target to $43 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Julian Harrison Maintained (ACRS) at Strong Buy with Decreased Target to $29 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Corinne Jenkins Maintained (ACRS) at Strong Buy with Decreased Target to $21 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Aydin Huseynov Initiated (ADVM) at Strong Buy and Held Target at $20 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Vernon Bernardino Reiterated (VTVT) at Strong Buy and Held Target at $240 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (vtle) at Hold with Increased Target to $61 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
James Thalacker Maintained (VST) at Buy with Increased Target to $35 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Adrienne Yih Maintained (VSCO) at Buy with Decreased Target to $38 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Rommel Dionisio Reiterated (VLCN) at Strong Buy on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (VNOM) at Buy with Decreased Target to $38 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Gregory Renza Reiterated (VRCA) at Buy and Held Target at $11 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Alexander Blostein Downgraded (APAM) to Strong Sell and Held Target at $27 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Richardson Maintained (APD) at Hold with Increased Target to $305 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (APA) at Hold with Decreased Target to $45 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Stringer Reiterated (ANNX) at Strong Buy and Held Target at $24 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Fein Reiterated (ANNX) at Strong Buy and Held Target at $30 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ng Initiated (ANET) at Strong Buy on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Michael Petusky Downgraded (ANIK) to Hold on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Chip Moore Reiterated (AMPX) at Strong Buy and Held Target at $14 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Jonathan Petersen Maintained (AMT) at Strong Buy with Increased Target to $244 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Youssef Squali Maintained (W) at Strong Buy with Decreased Target to $47 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Jeremy Tonet Maintained (USAC) at Sell with Increased Target to $20 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Harrigan Reiterated (SMSI) at Strong Buy and Held Target at $40 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Anupam Rama Maintained (SNDX) at Buy with Decreased Target to $36 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Stringer Reiterated (STOK) at Strong Buy and Held Target at $25 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Fein Reiterated (STOK) at Strong Buy and Held Target at $35 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Judah Frommer Maintained (STOK) at Buy with Decreased Target to $28 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Laura Chico Maintained (STOK) at Buy with Decreased Target to $25 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Charles Duncan Reiterated (STOK) at Buy and Held Target at $20 on, Mar 7th, 2023

Charles Duncan Reiterated (STOK) at Buy and Held Target at $20 on, Mar 7th, 2023


Published on 2024-10-28 02:08:51 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Reiterated "Stoke Therapeutics, Inc." (STOK) at Buy and Held Target at $20 on, Mar 7th, 2023.

Charles, nor any peers, have made any analyst calls on STOK in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources